These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9354011)

  • 1. Inhibition of phagocytosis of E. coli by B. fragilis group--an in vitro study.
    Beena VK; Kumari N; Shivananda PG
    Indian J Pathol Microbiol; 1997 Jul; 40(3):373-6. PubMed ID: 9354011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Killing of Escherichia coli by human polymorphonuclear leucocytes in the presence of Bacteroides fragilis.
    Vel WA; Namavar F; Verweij-van Vught AM; Pubben AN; MacLaren DM
    J Clin Pathol; 1985 Jan; 38(1):86-91. PubMed ID: 3881478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phagocytic and serum killing of capsulate and non-capsulate Bacteroides fragilis.
    Reid JH; Patrick S
    J Med Microbiol; 1984 Jun; 17(3):247-57. PubMed ID: 6726784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of capsular polysaccharide and lipopolysaccharide of Bacteroides fragilis on polymorph function and serum killing.
    Connolly JC; McLean C; Tabaqchali S
    J Med Microbiol; 1984 Jun; 17(3):259-71. PubMed ID: 6374150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial killing in vitro by abscess-derived neutrophils.
    Finlay-Jones JJ; Hart PH; Spencer LK; Nulsen MF; Kenny PA; McDonald PJ
    J Med Microbiol; 1991 Feb; 34(2):73-81. PubMed ID: 1990143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of anti-Bacteroides-antibodies on Escherichia coli and different Bacteroides species in vitro and vivo.
    Rodloff AC; Hilliger F; Friedman H; Hahn H
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Nov; 262(4):483-91. PubMed ID: 3541458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of phagocytosis in vitro by obligate anaerobes.
    Ingham HR; Sisson PR; Tharagonnet D; Selkon JB; Codd AA
    Lancet; 1977 Dec; 2(8051):1252-4. PubMed ID: 73952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between polymorphonuclear leucocytes, Bacteroides sp, and Escherichia coli: their role in the pathogenesis of mixed infection.
    Vel WA; Namavar F; Verweij-van Vught AM; Pubben AN; MacLaren DM
    J Clin Pathol; 1986 Apr; 39(4):376-82. PubMed ID: 3517072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of immunoglobulin M antibodies in normal human serum that participate in opsonophagocytosis and intracellular killing of Bacteroides fragilis and Bacteroides thetaiotaomicron by by human polymorphonuclear leukocytes.
    Bjornson AB; Bjornson HS; Kitko BP
    Infect Immun; 1980 Oct; 30(1):263-71. PubMed ID: 6160104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Bacteroides fragilis grown in the presence of clindamycin, metronidazole and fusidic acid on opsonization and killing of Escherichia coli.
    Namavar F; Kaan JA; Verweij-van Vught AM; Vel WA; Bal M; Kester AD; MacLaren DM
    Eur J Clin Microbiol; 1986 Jun; 5(3):324-9. PubMed ID: 3527702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro activity of peritoneal cells from rats after intra-abdominal infection with Bacteroides fragilis and Escherichia coli.
    Verweij WR; Namavar F; Schouten WF; Kostense PJ; Pellenkoft M; De Graaff J; MacClaren DM
    J Med Microbiol; 1993 Jan; 38(1):13-8. PubMed ID: 8380297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination patterns of Escherichia coli and bacteroides fragilis from the peritoneal cavity. Studies with experimental peritonitis in pigs.
    Nyström PO; Skau T
    Acta Chir Scand; 1983; 149(4):383-8. PubMed ID: 6351520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of humoral factors in host resistance to the Bacteroides fragilis group.
    Bjornson AB
    Rev Infect Dis; 1990; 12 Suppl 2():S161-8. PubMed ID: 2406868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Escherichia coli and Bacteroides fragilis on peritoneal host defenses.
    Dunn DL; Barke RA; Ewald DC; Simmons RL
    Infect Immun; 1985 May; 48(2):287-91. PubMed ID: 3886544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic synergy between Escherichia coli and Bacteroides fragilis or B. vulgatus in experimental infections: a non-specific phenomenon.
    Verweij-van Vught AM; Namavar F; Vel WA; Sparrius M; MacLaren DM
    J Med Microbiol; 1986 Feb; 21(1):43-7. PubMed ID: 3512833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A soluble Bacteroides by-product impairs phagocytic killing of Escherichia coli by neutrophils.
    Rotstein OD; Vittorini T; Kao J; McBurney MI; Nasmith PE; Grinstein S
    Infect Immun; 1989 Mar; 57(3):745-53. PubMed ID: 2537256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bactericidal action of human serum on Bacteroides species.
    Rotimi VO; Eke PI
    J Med Microbiol; 1984 Dec; 18(3):355-63. PubMed ID: 6502677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of killing of bacteria by guinea pig neutrophils and monocytes.
    Casciato DA; Bluestone R; Goldberg LS
    J Lab Clin Med; 1977 Aug; 90(2):273-82. PubMed ID: 328806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encapsulation and protection against phagocytosis by Bacteroides fragilis.
    Lindberg AA; Weintraub A
    Scand J Infect Dis Suppl; 1985; 46():27-32. PubMed ID: 3865350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in opsonophagocytic killing by neutrophils of Bacteroides fragilis associated with animal and laboratory passage: effect of capsular polysaccharide.
    Simon GL; Klempner MS; Kasper DL; Gorbach SL
    J Infect Dis; 1982 Jan; 145(1):72-7. PubMed ID: 7054319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.